CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Australia

5 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
The Alfred Hospital, Melbourne · Gold Coast University Hospital, Parkwood
Registry updated 2026-11-03
NCT06920004
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Trial Treatment · Phase 3 · argenx
Liverpool Hospital, Liverpool
Registry updated 2026-11-03
NCT06858579
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Liverpool · Melbourne · Randwick · Saint Leonards · Southport · Sydney
Registry updated 2026-10-28
NCT07304154
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Trial Treatment · Phase 1 · Kite, A Gilead Company
Concord Repatriation General Hospital, Sydney · Corner Hawkesbury Road and Darcy Road, Westmead
Registry updated 2026-10-19
NCT07032662
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2 · Immunovant Sciences GmbH
Macquarie Park · Parkville · Woolloongabba
Registry updated 2026-09-30

This page is not medical advice. Talk to your doctor before contacting a trial.

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)